Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up

The aim of this clinical trial (ID Number NCT01803347) was to determine the safety and efficacy of autologous adipose-derived stem cells (ASCs) for treatment of cryptoglandular fistula. This research was conducted following an analysis of the mistakes of a same previous phase III clinical trial. We...

Descripción completa

Detalles Bibliográficos
Autores: García-Arranz, M. (Mariano)|||/items/2975353c-dcc6-482f-93e9-60b5dec8d4b5, Garcia-Olmos, D. (Damián)|||/items/326e762c-fb72-468b-87f4-ecae2c861998, Herreros, M.D. (María Dolores)|||/items/5f7ca674-900a-4834-a92e-ab5374f1e7d0, Gracia-Solana, J. (José)|||/items/92105c65-715d-4b4e-abe9-95512c92cbcb, Guadalajara, H. (Héctor)|||/items/cd73ff10-d4bb-426c-b7c9-0741bac4430c, de-la-Portilla, F. (Fernando)|||/items/c5afd819-79e9-4562-858f-87f4c222dc5e, Baixauli-Fons, J. (Jorge)|||/items/c863985d-f450-4807-a4fe-56d26f6e8dfa, Garcia-Garcia, J. (Jacinto)|||/items/57fca8ad-e34d-4e81-a9d9-cb1ccd6ea8cc, Ramirez, J.M. (José Manuel)|||/items/e5ef340d-f995-4a9b-9168-c1f62eb2026d, Sanchez-Guijo, F.M. (Fermín M.)|||/items/b31fe6cf-bc6a-42fb-8a92-116c4f62dd49, Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/65509
Acceso en línea:https://hdl.handle.net/10171/65509
Access Level:acceso abierto
Palabra clave:Complex cryptoglandular fistula
Mesenchymal stem cells
Phase III
id ES_2ed9f5bd4d61bb9813a0bd2f9cf9d2bd
oai_identifier_str oai:dadun.unav.edu:10171/65509
network_acronym_str ES
network_name_str España
repository_id_str
spelling Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-upGarcía-Arranz, M. (Mariano)|||/items/2975353c-dcc6-482f-93e9-60b5dec8d4b5Garcia-Olmos, D. (Damián)|||/items/326e762c-fb72-468b-87f4-ecae2c861998Herreros, M.D. (María Dolores)|||/items/5f7ca674-900a-4834-a92e-ab5374f1e7d0Gracia-Solana, J. (José)|||/items/92105c65-715d-4b4e-abe9-95512c92cbcbGuadalajara, H. (Héctor)|||/items/cd73ff10-d4bb-426c-b7c9-0741bac4430cde-la-Portilla, F. (Fernando)|||/items/c5afd819-79e9-4562-858f-87f4c222dc5eBaixauli-Fons, J. (Jorge)|||/items/c863985d-f450-4807-a4fe-56d26f6e8dfaGarcia-Garcia, J. (Jacinto)|||/items/57fca8ad-e34d-4e81-a9d9-cb1ccd6ea8ccRamirez, J.M. (José Manuel)|||/items/e5ef340d-f995-4a9b-9168-c1f62eb2026dSanchez-Guijo, F.M. (Fermín M.)|||/items/b31fe6cf-bc6a-42fb-8a92-116c4f62dd49Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1Complex cryptoglandular fistulaMesenchymal stem cellsPhase IIIThe aim of this clinical trial (ID Number NCT01803347) was to determine the safety and efficacy of autologous adipose-derived stem cells (ASCs) for treatment of cryptoglandular fistula. This research was conducted following an analysis of the mistakes of a same previous phase III clinical trial. We designed a multicenter, randomized, single-blind clinical trial, recruiting 57 patients. Forty-four patients were categorized as belonging to the intent-to-treat group. Of these, 23 patients received 100 million ASCs plus intralesional fibrin glue (group A) and 21 received intralesional fibrin glue (group B), both after a deeper curettage of tracks and closure of internal openings. Fistula healing was defined as complete re-epithelialization of external openings. Those patients in whom the fistula had not healed after 16 weeks were eligible for retreatment. Patients were evaluated at 1, 4, 16, 36, and 52 weeks and 2 years after treatment. Results were assessed by an evaluator blinded to the type of treatment. After 16 weeks, the healing rate was 30.4% in group A and 42.8% in group B, rising to 55.0% and 63.1%, respectively, at 52 weeks. At the end of the study (2 years after treatment), the healing rate remained at 50.0% in group A and had reduced to 26.3% in group B. The safety of the cellular treatment was confirmed and no impact on fecal continence was detected. The main conclusion was that autologous ASCs for the treatment of cryptoglandular perianal fistula is safe and can favor long-term and sustained fistula healing.WileyDadun. Depósito Académico Digital Universidad de Navarra20232023-02-2020202020-01-0120202020-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/65509reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/655092026-06-21T12:47:57Z
dc.title.none.fl_str_mv Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
title Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
spellingShingle Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
García-Arranz, M. (Mariano)|||/items/2975353c-dcc6-482f-93e9-60b5dec8d4b5
Complex cryptoglandular fistula
Mesenchymal stem cells
Phase III
title_short Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
title_full Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
title_fullStr Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
title_full_unstemmed Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
title_sort Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: a randomized clinical trial with long-term follow-up
dc.creator.none.fl_str_mv García-Arranz, M. (Mariano)|||/items/2975353c-dcc6-482f-93e9-60b5dec8d4b5
Garcia-Olmos, D. (Damián)|||/items/326e762c-fb72-468b-87f4-ecae2c861998
Herreros, M.D. (María Dolores)|||/items/5f7ca674-900a-4834-a92e-ab5374f1e7d0
Gracia-Solana, J. (José)|||/items/92105c65-715d-4b4e-abe9-95512c92cbcb
Guadalajara, H. (Héctor)|||/items/cd73ff10-d4bb-426c-b7c9-0741bac4430c
de-la-Portilla, F. (Fernando)|||/items/c5afd819-79e9-4562-858f-87f4c222dc5e
Baixauli-Fons, J. (Jorge)|||/items/c863985d-f450-4807-a4fe-56d26f6e8dfa
Garcia-Garcia, J. (Jacinto)|||/items/57fca8ad-e34d-4e81-a9d9-cb1ccd6ea8cc
Ramirez, J.M. (José Manuel)|||/items/e5ef340d-f995-4a9b-9168-c1f62eb2026d
Sanchez-Guijo, F.M. (Fermín M.)|||/items/b31fe6cf-bc6a-42fb-8a92-116c4f62dd49
Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
author García-Arranz, M. (Mariano)|||/items/2975353c-dcc6-482f-93e9-60b5dec8d4b5
author_facet García-Arranz, M. (Mariano)|||/items/2975353c-dcc6-482f-93e9-60b5dec8d4b5
Garcia-Olmos, D. (Damián)|||/items/326e762c-fb72-468b-87f4-ecae2c861998
Herreros, M.D. (María Dolores)|||/items/5f7ca674-900a-4834-a92e-ab5374f1e7d0
Gracia-Solana, J. (José)|||/items/92105c65-715d-4b4e-abe9-95512c92cbcb
Guadalajara, H. (Héctor)|||/items/cd73ff10-d4bb-426c-b7c9-0741bac4430c
de-la-Portilla, F. (Fernando)|||/items/c5afd819-79e9-4562-858f-87f4c222dc5e
Baixauli-Fons, J. (Jorge)|||/items/c863985d-f450-4807-a4fe-56d26f6e8dfa
Garcia-Garcia, J. (Jacinto)|||/items/57fca8ad-e34d-4e81-a9d9-cb1ccd6ea8cc
Ramirez, J.M. (José Manuel)|||/items/e5ef340d-f995-4a9b-9168-c1f62eb2026d
Sanchez-Guijo, F.M. (Fermín M.)|||/items/b31fe6cf-bc6a-42fb-8a92-116c4f62dd49
Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
author_role author
author2 Garcia-Olmos, D. (Damián)|||/items/326e762c-fb72-468b-87f4-ecae2c861998
Herreros, M.D. (María Dolores)|||/items/5f7ca674-900a-4834-a92e-ab5374f1e7d0
Gracia-Solana, J. (José)|||/items/92105c65-715d-4b4e-abe9-95512c92cbcb
Guadalajara, H. (Héctor)|||/items/cd73ff10-d4bb-426c-b7c9-0741bac4430c
de-la-Portilla, F. (Fernando)|||/items/c5afd819-79e9-4562-858f-87f4c222dc5e
Baixauli-Fons, J. (Jorge)|||/items/c863985d-f450-4807-a4fe-56d26f6e8dfa
Garcia-Garcia, J. (Jacinto)|||/items/57fca8ad-e34d-4e81-a9d9-cb1ccd6ea8cc
Ramirez, J.M. (José Manuel)|||/items/e5ef340d-f995-4a9b-9168-c1f62eb2026d
Sanchez-Guijo, F.M. (Fermín M.)|||/items/b31fe6cf-bc6a-42fb-8a92-116c4f62dd49
Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Complex cryptoglandular fistula
Mesenchymal stem cells
Phase III
topic Complex cryptoglandular fistula
Mesenchymal stem cells
Phase III
description The aim of this clinical trial (ID Number NCT01803347) was to determine the safety and efficacy of autologous adipose-derived stem cells (ASCs) for treatment of cryptoglandular fistula. This research was conducted following an analysis of the mistakes of a same previous phase III clinical trial. We designed a multicenter, randomized, single-blind clinical trial, recruiting 57 patients. Forty-four patients were categorized as belonging to the intent-to-treat group. Of these, 23 patients received 100 million ASCs plus intralesional fibrin glue (group A) and 21 received intralesional fibrin glue (group B), both after a deeper curettage of tracks and closure of internal openings. Fistula healing was defined as complete re-epithelialization of external openings. Those patients in whom the fistula had not healed after 16 weeks were eligible for retreatment. Patients were evaluated at 1, 4, 16, 36, and 52 weeks and 2 years after treatment. Results were assessed by an evaluator blinded to the type of treatment. After 16 weeks, the healing rate was 30.4% in group A and 42.8% in group B, rising to 55.0% and 63.1%, respectively, at 52 weeks. At the end of the study (2 years after treatment), the healing rate remained at 50.0% in group A and had reduced to 26.3% in group B. The safety of the cellular treatment was confirmed and no impact on fecal continence was detected. The main conclusion was that autologous ASCs for the treatment of cryptoglandular perianal fistula is safe and can favor long-term and sustained fistula healing.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01
2020
2020-01-01
2023
2023-02-20
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/65509
url https://hdl.handle.net/10171/65509
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405438332633088
score 15.300724